Myriad Genetics, Inc. (NASDAQ:MYGN) closed its last session at $20.71 with the change of -0.24%. The market capitalization of the company is $1.43B with an average Volume of 1.69 million shares. The stock currently has its 52-Week High range of $46.24 and 52-week low range of $19.10. The Price to Book (P/B) ratio stands at 1.92. The stock traded total quantity of 1.47 million shares.
Currently Myriad Genetics, Inc. (MYGN) captured an average recommendation of “ Hold ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “5″ Analysts”. “3” rated “Sell” for the company. “8” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “1”.
Analysts are expecting that the company to achieve $23.75 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $42.00 however minimum price target advised by analysts is $18.00. The Median price target for the stock is measured at $21.50.
Presently, Analysts decided consensus EPS estimate of $0.26 for present quarter and one month ago projected EPS estimate was at $0.26. If we take a look at back 3 month ago, consensus EPS estimate was $0.42.
A current consensus EPS estimate for next quarter is at $0.27 and 3 month ago EPS forecast was $0.46. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.28.
For current fiscal year, most recent EPS estimate is set at $1.05 based on Analyst consensus and three month ago consensus EPS opinions was at $1.78. During period one month ago, consensus EPS forecast was decided at $1.06.
A current consensus EPS projection for next fiscal year is observed at $1.24 and one month ago consensus EPS forecast was at $1.24. Take a look at back three month ago, consensus EPS estimate opinions was decided at $1.89 by analysts.
One Month ago, the stock has gained consensus mean rating of Hold based on the analysis of brokerage analyst firms polled. 5 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 9 advised the “Hold” rating about this stock. 3 revealed “Sell” signal and “Underweight” rating was declared by 1.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 8 said a “Buy Rating” and 0 announced “Overweight Rating”. 8 advised “Hold Rating” regarding the stock. 3 announced “Sell Rating” and 0 disclosed “Underweight Rating”.